Eric Lefebvre
Hoofd Techniek/Wetenschap/O&O bij PLIANT THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Eric Lefebvre
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
25
| Subsidiary | Pharmaceuticals: Major | 25 |
| Subsidiary | Pharmaceuticals: Major | 18 | |
| Subsidiary | Biotechnology | 16 | |
Fonds D Investissement De La Culture Et Des Communications, LP
 Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal.
10
| Private Company | Investment Managers | 10 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Eric Lefebvre via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member Corporate Officer/Principal Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Treasurer Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | President Treasurer Director/Board Member | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Dey Laboratories, Inc. | President General Counsel | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member President Treasurer | |
Janssen LP
 Janssen LP Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen LP is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Titusville, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer General Counsel | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer General Counsel | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Compliance Officer Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Ierland | 2 |
| Zwitserland | 2 |
| Verenigd Koninkrijk | 2 |
| Bermuda | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 538 |
| Corporate Officer/Principal | 261 |
| Independent Dir/Board Member | 198 |
| Chief Executive Officer | 100 |
| President | 92 |
Sterkste connecties
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Pierre Legault | 45 |
| Patrick Heron | 42 |
| Tamar Howson | 41 |
| Perry Karsen | 38 |
| Kurt von Emster | 34 |
| Neil Exter | 33 |
| Ho Young Huh | 32 |
| Ambrose Bailey | 32 |
| Thomas Wiggans | 31 |
| Richard Kollender | 30 |
| Charles Homcy | 29 |
| David Pyott | 27 |
| Dennis Podlesak | 27 |
| Elizabeth Anderson | 25 |
- Beurs
- Insiders
- Eric Lefebvre
- Bedrijfsconnecties
